Moderna (NASDAQ: MRNA) shares are down just over 1% in early Friday trading after the company said the FDA has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE